CLINICAL TRIAL PATIENT TECHNOLOGY INSIGHTS
-
Real-World Evidence And Wearables Are Reshaping Trial Tech
ISPOR’s Rob Abbott on why RWE moved to number two in the 2026-2027 HEOR Trends Report, and what wearables, data fragmentation, and HARPER+ mean for clinical platforms.
-
HEOR, AI, And The Future Of Clinical Trial Technology
ISPOR CEO Rob Abbott on why HEOR must be in the room when clinical trial tech is built, and what ISPOR’s latest Top 10 HEOR Trends Report means for ClinOps.
ECOA RESOURCES
-
When caregivers are involved in a clinical trial, remember to utilize these tactics to ensure that the completion of Observer Reported Outcomes is user-friendly and upholds data quality standards.
-
Watch as speakers explore the experiences of sites conducting digital and hybrid trials, discussing the critical benefits of a change management strategy and a unified digital trial platform.
-
See how digital solutions came together to enable faster study startup by 50% for this top pharma company conducting a Phase 3 diabetes study within the weight loss market.
ECONSENT RESOURCES
-
Director of Partners and Alliance Management at HealthVerity KC Ahlberg discusses some key trends related to the use of real-world data in clinical trials, and the value sponsors are realizing through data linkage.
-
Watch as speakers explore the experiences of sites conducting digital and hybrid trials, discussing the critical benefits of a change management strategy and a unified digital trial platform.
-
This blog post examines eConsent vs. ICF on comprehension, acceptability, enrollment, retention, consent time, and site workload.
EPRO RESOURCES
-
In honor of World Movement Disorders Day, we highlight advances in Parkinson’s disease care. At the 2024 MDS Congress, Signant presented research on electronic diaries for tracking PD patients' functional status.
-
Discover how to enable patient- and site-centric data collection, enhance participant engagement, reduce burden, and deliver valuable real-world insights on treatment effectiveness and quality of life.
-
Kelly Dumais, Principal Scientific Advisor, and Jowita Marszewska, Scientific Advisor at Clario eCOA, delve into the specifics of how recent regulatory advancements are influencing PRO Strategy.